| __timestamp | Bausch Health Companies Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 152500000 |
| Thursday, January 1, 2015 | 582800000 | 187800000 |
| Friday, January 1, 2016 | 455000000 | 184000000 |
| Sunday, January 1, 2017 | 366000000 | 167700000 |
| Monday, January 1, 2018 | 414000000 | 218600000 |
| Tuesday, January 1, 2019 | 471000000 | 187400000 |
| Wednesday, January 1, 2020 | 452000000 | 177700000 |
| Friday, January 1, 2021 | 465000000 | 122000000 |
| Saturday, January 1, 2022 | 529000000 | 123100000 |
| Sunday, January 1, 2023 | 604000000 | 122500000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. This chart compares the research and development (R&D) expenses of Perrigo Company plc and Bausch Health Companies Inc. over the past decade. From 2014 to 2023, Bausch Health consistently outspent Perrigo, with its R&D expenses peaking at approximately 604 million in 2023, marking a 145% increase from 2014. In contrast, Perrigo's R&D spending saw a decline, dropping to around 122 million in 2023, a 20% decrease from its 2018 peak. This divergence highlights Bausch Health's commitment to innovation, while Perrigo appears to be scaling back. As the pharmaceutical industry faces new challenges and opportunities, these spending patterns may influence their future market positions.
AbbVie Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Novartis AG vs Perrigo Company plc
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated